SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
S-3/A	Pre-effective amendment to an S-3 filing	Sep 8, 2003	View HTML 0001047469-03-030141.pdf 0001047469-03-030141.rtf 0001047469-03-030141.xls
S-3/A	Pre-effective amendment to an S-3 filing	Aug 15, 2003	View HTML 0001047469-03-027810.pdf 0001047469-03-027810.rtf 0001047469-03-027810.xls
3	Initial filing by director officer or owner of more than ten percent.	Aug 12, 2003	View HTML 0001179110-03-005350.pdf 0001179110-03-005350.rtf 0001179110-03-005350.xls
4	Statement of changes in beneficial ownership of securities	Aug 12, 2003	View HTML 0001179110-03-005368.pdf 0001179110-03-005368.rtf 0001179110-03-005368.xls
10-Q	Quarterly report which provides a continuing view of a company's financial position	Aug 1, 2003	View HTML 0001104659-03-016390.pdf 0001104659-03-016390.rtf 0001104659-03-016390.xls
4	Statement of changes in beneficial ownership of securities	Jul 24, 2003	View HTML 0001179110-03-004101.pdf 0001179110-03-004101.rtf 0001179110-03-004101.xls
4	Statement of changes in beneficial ownership of securities	Jul 24, 2003	View HTML 0001179110-03-004106.pdf 0001179110-03-004106.rtf 0001179110-03-004106.xls
8-K	Report of unscheduled material events or corporate event	Jul 23, 2003	View HTML 0001157523-03-003171.pdf 0001157523-03-003171.rtf
REGDEX	REGDEX	Jul 21, 2003	View HTML 9999999997-03-030093.pdf 9999999997-03-030093.rtf
SC 13G	A statement of beneficial ownership of common stock by certain persons	Jul 10, 2003	View HTML 0000902664-03-000883.pdf 0000902664-03-000883.rtf

Data provided by Kaleidoscope.